Clinical Trial Update: Cardiovascular Safety Study of Lodenafil Carbonate in Patients With Coronaropathy During Physical Effort [Phase 4]

View source ↗

Summary

Phase 4 cardiovascular safety study of lodenafil carbonate in patients with erectile dysfunction and coronary artery disease has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Erectile Dysfunction

Drugs mentioned

• Lodenafil Carbonate (lodenafil carbonate)

Snippet

Sponsor: Cristália Produtos Químicos Farmacêuticos Ltda. | Conditions: Erectile Dysfunction, Coronaropathy | Phase 4 | Status: WITHDRAWN